Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Authors
Keywords
-
Journal
Biomolecules
Volume 12, Issue 7, Pages 909
Publisher
MDPI AG
Online
2022-06-29
DOI
10.3390/biom12070909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial
- (2022) Lara J. Farrell et al. DEPRESSION AND ANXIETY
- Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor
- (2022) Michael Desch et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
- (2022) Ryo Ochi et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice
- (2022) Kentaro Takayama et al. ACS Medicinal Chemistry Letters
- Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy
- (2022) Wangxiao He et al. Theranostics
- A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro
- (2022) Isabelle Aillaud et al. Alzheimers Research & Therapy
- Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients
- (2022) Arianna De Rosa et al. Biomolecules
- Mammalian D‐cysteine: A novel regulator of neural progenitor cell proliferation
- (2022) Robin Roychaudhuri et al. BIOESSAYS
- Cognitive Dysfunction and Prefrontal Cortical Circuit Alterations in Schizophrenia: Developmental Trajectories
- (2022) Samuel J. Dienel et al. BIOLOGICAL PSYCHIATRY
- Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
- (2022) Haifeng Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia
- (2022) Shalini Dogra et al. MOLECULAR PHARMACOLOGY
- Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
- (2022) Masataka Wada et al. MOLECULAR PSYCHIATRY
- The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight
- (2022) Andrea de Bartolomeis et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study
- (2022) Li-Chung Huang et al. PSYCHOLOGICAL MEDICINE
- Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
- (2022) Christoph U. Correll et al. npj Schizophrenia
- Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
- (2022) Arianna De Rosa et al. npj Schizophrenia
- Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia
- (2022) Silas A. Buck et al. MOLECULAR PSYCHIATRY
- Efficacy of adjunctive d-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials
- (2021) Pooja Patnaik Kuppili et al. JOURNAL OF NEURAL TRANSMISSION
- Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
- (2021) Kah Kheng Goh et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Measuring amphetamine‐induced dopamine release in humans: A comparative meta‐analysis of [ 11 C]‐raclopride and [ 11 C]‐(+)‐PHNO studies
- (2021) Fernando Caravaggio et al. SYNAPSE
- Sarcosine as an add-on treatment to antipsychotic medication for people with schizophrenia: a systematic review and meta-analysis of randomized controlled trials
- (2021) Mattia Marchi et al. Expert Opinion on Drug Metabolism & Toxicology
- An NRP1/MDM2‐Targeted D‐Peptide Supramolecular Nanomedicine for High‐Efficacy and Low‐Toxic Liver Cancer Therapy
- (2021) Yunjiang Zhou et al. Advanced Healthcare Materials
- Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis
- (2021) Annarita Barone et al. BEHAVIOURAL BRAIN RESEARCH
- TEMPORARY REMOVAL: D-cycloserine normalizes long-term motor plasticity after transcranial magnetic intermittent theta-burst stimulation in major depressive disorder
- (2021) Jaeden Cole et al. CLINICAL NEUROPHYSIOLOGY
- Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia
- (2021) Eduard Parellada et al. Translational Psychiatry
- Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia
- (2021) Jaromir Hons et al. Frontiers in Psychiatry
- Modulation of Glycinergic Neurotransmission may Contribute to the Analgesic Effects of Propacetamol
- (2021) Lukas Barsch et al. Biomolecules
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. Systematic Reviews
- Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy
- (2021) Aviv Segev et al. BRITISH JOURNAL OF PSYCHIATRY
- Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
- (2021) Marwa Malhis et al. CHEMBIOCHEM
- Evidence for Altered Phosphoinositide Signaling-Associated Molecules in the Postmortem Prefrontal Cortex of Patients with Schizophrenia
- (2021) Yasuto Kunii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction
- (2021) Shekib Ahmad Jami et al. JOURNAL OF NEUROPHYSIOLOGY
- Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine
- (2021) Glenn Dallérac et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
- (2021) Dara Gammon et al. Biomolecules
- Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy
- (2021) Andy Kuo et al. Biomolecules
- Glycine Receptors in Spinal Nociceptive Control—An Update
- (2021) Hanns Ulrich Zeilhofer et al. Biomolecules
- Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling
- (2021) Christopher L. Cioffi Biomolecules
- Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
- (2021) Loredano Pollegioni et al. Frontiers in Molecular Biosciences
- Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2
- (2021) Pedro A. Valiente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
- (2021) Pontus Plavén-Sigray et al. MOLECULAR PSYCHIATRY
- D-Amino Acids and D-Amino Acid-Containing Peptides: Potential Disease Biomarkers and Therapeutic Targets?
- (2021) Mohamed Abdulbagi et al. Biomolecules
- Glycine Transporters and Receptors as Targets for Analgesics
- (2021) Robert J. Harvey et al. Biomolecules
- Efficacy and safety of add-on sodium benzoate, a D-amino acid oxidase inhibitor, in treatment of schizophrenia: A systematic review and meta-analysis
- (2021) Jyothsna Chinnapura Seetharam et al. Asian Journal of Psychiatry
- finDr: A web server for in silico D-peptide ligand identification
- (2021) Helena Engel et al. Synthetic and Systems Biotechnology
- Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins
- (2021) G.L. Collingridge et al. NEUROPHARMACOLOGY
- Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
- (2021) Marta Matrone et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients
- (2021) Francisco Reyes-Madrigal et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial
- (2020) Philip D. Harvey et al. CLINICAL DRUG INVESTIGATION
- Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management
- (2020) Kevin C.F. Fone et al. MOLECULAR NEUROBIOLOGY
- Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models
- (2020) Da-Zhong Luo et al. Scientific Reports
- Prenatal expression of d-aspartate oxidase causes early cerebral d-aspartate depletion and influences brain morphology and cognitive functions at adulthood
- (2020) Arianna De Rosa et al. AMINO ACIDS
- Serine Racemase Expression by Striatal Neurons
- (2020) Shunsuke Takagi et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
- (2020) Danielle Gouvêa-Junqueira et al. Frontiers in Psychiatry
- Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
- (2020) Andrea de Bartolomeis et al. Frontiers in Psychiatry
- Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[11C]methoxyphenethyl)pyridazin-3(2H)-one, a 11C-labeled -amino acid oxidase (DAAO) inhibitor for PET imaging
- (2020) Xiaoyun Deng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat
- (2020) Susanne Nikolaus et al. REVIEWS IN THE NEUROSCIENCES
- Multi-Scale Understanding of NMDA Receptor Function in Schizophrenia
- (2020) Jo Soo Hyun et al. Biomolecules
- Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder
- (2020) Gerd Kvale et al. JAMA Network Open
- New insights on the influence of free d-aspartate metabolism in the mammalian brain during prenatal and postnatal life
- (2020) Francesco Errico et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- d-Serine and d-Alanine Regulate Adaptive Foraging Behavior in Caenorhabditis elegans via the NMDA Receptor
- (2020) Yasuaki Saitoh et al. JOURNAL OF NEUROSCIENCE
- Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
- (2020) Alice Egerton et al. SCHIZOPHRENIA BULLETIN
- Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
- (2020) Alice Egerton et al. SCHIZOPHRENIA RESEARCH
- Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis
- (2020) Susan F. Sonnenschein et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Multiple Rare Risk Coding Variants in Postsynaptic Density-Related Genes Associated With Schizophrenia Susceptibility
- (2020) Tsung-Ming Hu et al. Frontiers in Genetics
- Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
- (2019) Antonio Rampino et al. Frontiers in Psychiatry
- Chronic phencyclidine treatment impairs spatial working memory in rhesus monkeys
- (2019) Bo Zhang et al. PSYCHOPHARMACOLOGY
- A Post-hoc Study of D-Amino Acid Oxidase in Blood as an Indicator of Post-stroke Dementia
- (2019) Yi-Chun Chen et al. Frontiers in Neurology
- D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
- (2019) Mary-Anne B. MacKay et al. Frontiers in Psychiatry
- Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
- (2019) Agnieszka Jankowska et al. CURRENT MEDICINAL CHEMISTRY
- Subsaturation of the N‐methyl‐D‐aspartate receptor glycine site allows the regulation of bursting activity in juvenile rat nigral dopamine neurons
- (2019) Geoffrey Destreel et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings
- (2019) Kenji Hashimoto Current Psychiatry Reports
- Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
- (2019) Fukuyama et al. Biomolecules
- Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia
- (2019) Andrea de Bartolomeis et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Sociality deficits in serine racemase knockout mice
- (2019) Tatyana M. Matveeva et al. Brain and Behavior
- Biophysical Psychiatry—How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders
- (2019) Tuomo Mäki-Marttunen et al. Frontiers in Psychiatry
- The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model
- (2019) Lulu Yao et al. BMC Psychiatry
- Structure and kinetic properties of human d ‐aspartate oxidase, the enzyme‐controlling d ‐aspartate levels in brain
- (2019) Gianluca Molla et al. FASEB JOURNAL
- Schizophrenia in a genomic era
- (2019) Mansour Zamanpoor PSYCHIATRIC GENETICS
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
- (2019) Ryosuke Tarumi et al. NEUROPSYCHOPHARMACOLOGY
- Lack of Effect of Sodium Benzoate at Reported Clinical Therapeutic Concentration on d-Alanine Metabolism in Dogs
- (2018) Michael Popiolek et al. ACS Chemical Neuroscience
- In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time–Averaged Proton Magnetic Resonance Spectroscopy at 4T
- (2018) Sang-Young Kim et al. BIOLOGICAL PSYCHIATRY
- Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)
- (2018) Dominik Strzelecki et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- d -Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner
- (2018) Kirsten C. Svane et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Accessing Gene Expression in Treatment-Resistant Schizophrenia
- (2018) Patricia N. Moretti et al. MOLECULAR NEUROBIOLOGY
- Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
- (2018) João M. N. Duarte et al. NEUROCHEMICAL RESEARCH
- Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables
- (2018) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Schizophrenia: synthetic strategies and recent advances in drug design
- (2018) Maria Azmanova et al. MedChemComm
- Emerging Role of D-Amino Acid Metabolism in the Innate Defense
- (2018) Jumpei Sasabe et al. Frontiers in Microbiology
- Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
- (2018) Liisa Leppik et al. Frontiers in Psychiatry
- D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?
- (2018) Paul J. Harrison BIOLOGICAL PSYCHIATRY
- Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient
- (2018) Emmanuel Pinard et al. CHIMIA
- Social brain, social dysfunction and social withdrawal
- (2018) Stefano Porcelli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Association between increased serum d -serine and cognitive gains induced by intensive cognitive training in schizophrenia
- (2018) Rogerio Panizzutti et al. SCHIZOPHRENIA RESEARCH
- DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia
- (2018) Simona Keller et al. Scientific Reports
- Astrocytic Regulation of Glutamate Transmission in Schizophrenia
- (2018) Yu-Ying Mei et al. Frontiers in Psychiatry
- Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
- (2018) Felice Iasevoli et al. Frontiers in Psychiatry
- The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
- (2018) Francesco Errico et al. Frontiers in Psychiatry
- Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
- (2017) Carmine Tomasetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neurophysiological Effects of Bitopertin in Schizophrenia
- (2017) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain
- (2017) Vinita Jagannath et al. Frontiers in Neuroanatomy
- Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
- (2017) Chieh-Hsin Lin et al. Scientific Reports
- D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders
- (2017) David Mataix-Cols et al. JAMA Psychiatry
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial
- (2017) Geoffrey W. Melville et al. PLoS One
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity
- (2017) Silvia Sacchi et al. Scientific Reports
- Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
- (2016) Christopher L. Cioffi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases
- (2016) Long Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD
- (2016) Megan Olden et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect
- (2016) Camilo Rojas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons
- (2016) Paraskevi Krashia et al. NEUROPHARMACOLOGY
- Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
- (2016) Euitae Kim et al. NEUROPSYCHOPHARMACOLOGY
- Phosphoserine phosphatase activity is elevated and correlates negatively with plasma d-serine concentration in patients with schizophrenia
- (2016) Yuji Ozeki et al. PSYCHIATRY RESEARCH
- Imaging hydrogen peroxide in Alzheimer’s disease via cascade signal amplification
- (2016) Jian Yang et al. Scientific Reports
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- Characterization of the Enzymatic and Structural Properties of Human D-Aspartate Oxidase and Comparison with Those of the Rat and Mouse Enzymes
- (2015) Masumi Katane et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- d-amino acid oxidase knockout (Dao−/−) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption
- (2015) David Pritchett et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
- (2015) Dominik Strzelecki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
- (2015) M. E. Goldstein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dynamic Regulation ofN-Methyl-d-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by Posttranslational Modifications
- (2015) Marc P. Lussier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models
- (2015) L.-L. Li et al. JOURNAL OF NEUROSCIENCE
- d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia
- (2015) Francesco Errico et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Three and six grams supplementation of d-aspartic acid in resistance trained men
- (2015) Geoffrey W Melville et al. Journal of the International Society of Sports Nutrition
- d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain
- (2015) Luigia Cristino et al. NEUROBIOLOGY OF AGING
- Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic 1NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia
- (2015) Dominik Strzelecki et al. NEUROSCIENCE LETTERS
- D-aspartate dysregulation in Ddo−/− mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum
- (2015) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
- (2015) Elias Mouchlianitis et al. SCHIZOPHRENIA BULLETIN
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
- (2015) Chun-Yuan Lin et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The desensitization gate of inhibitory Cys-loop receptors
- (2015) Marc Gielen et al. Nature Communications
- Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia
- (2015) Dominik Strzelecki et al. Nutrients
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- A Randomized, Double-Blind Evaluation ofd-Cycloserine or Alprazolam Combined With Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder in Iraq and Afghanistan War Veterans
- (2014) Barbara Olasov Rothbaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
- (2014) Felice Iasevoli et al. Current Neuropharmacology
- Increased burst-firing of ventral tegmental area dopaminergic neurons ind-amino acid oxidase knockout micein vivo
- (2014) Judith V. Schweimer et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- A Genetically Informed, Group fMRI Connectivity Modeling Approach: Application to Schizophrenia
- (2014) Aiping Liu et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Motor Impairments, Striatal Degeneration, and Altered Dopamine-Glutamate Interplay in Mice Lacking PSD-95
- (2014) Jingping Zhang et al. JOURNAL OF NEUROGENETICS
- Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice
- (2014) Jongho Kim et al. MOLECULAR IMAGING AND BIOLOGY
- Psychiatric Risk Factor ANK3/Ankyrin-G Nanodomains Regulate the Structure and Function of Glutamatergic Synapses
- (2014) Katharine R. Smith et al. NEURON
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
- (2014) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Evaluation of human D-amino acid oxidase inhibition by anti-psychotic drugs in vitro
- (2014) Miho Shishikura et al. BioScience Trends
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals
- (2014) F Errico et al. Translational Psychiatry
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia
- (2013) Francesco Errico et al. JOURNAL OF PSYCHIATRIC RESEARCH
- d-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions
- (2013) Jasper A.J. Smits et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches
- (2013) Andrea de Bartolomeis et al. MOLECULAR NEUROBIOLOGY
- Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
- (2013) Hiroko Hagiwara et al. PLoS One
- Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis
- (2013) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
- (2013) Andrea de Bartolomeis et al. PSYCHIATRY RESEARCH
- NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
- (2013) X Zhou et al. Cell Death & Disease
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- New insights on the role of free d-aspartate in the mammalian brain
- (2012) Francesco Errico et al. AMINO ACIDS
- d-Amino acids in brain neurotransmission and synaptic plasticity
- (2012) Jean-Marie Billard AMINO ACIDS
- A frontier in the understanding of synaptic plasticity: Solving the structure of the postsynaptic density
- (2012) Matthew G. Gold BIOESSAYS
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
- (2012) Thomas Papouin et al. CELL
- d-Serine: A key to synaptic plasticity?
- (2012) Christian Henneberger et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Different serine and glycine metabolism in patients with schizophrenia receiving clozapine
- (2012) Jaromir Hons et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion
- (2012) T M Ma et al. MOLECULAR PSYCHIATRY
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation
- (2012) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD)
- (2012) C. Luscher et al. Cold Spring Harbor Perspectives in Biology
- Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
- (2011) Oliver D. Howes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- PKCβ-dependent phosphorylation of the glycine transporter 1
- (2011) Javier Vargas-Medrano et al. NEUROCHEMISTRY INTERNATIONAL
- Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls
- (2011) Sergio Alessandro Papagni et al. NEUROIMAGE
- NMDA receptors: Recent insights and clinical correlations
- (2011) E. E. Benarroch NEUROLOGY
- GABAergic interneuron origin of schizophrenia pathophysiology
- (2011) Kazu Nakazawa et al. NEUROPHARMACOLOGY
- Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
- (2011) Daniela Alberati et al. NEUROPHARMACOLOGY
- Effects of low-dose d-serine on recognition and working memory in mice
- (2011) Patricia Bado et al. PSYCHOPHARMACOLOGY
- Inhibition of D-Amino Acid Oxidase Activity by Antipsychotic Drugs Evaluated by a Fluorometric Assay Using D-Kynurenine as Substrate
- (2011) Sumiko IWASA et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Oral Treatment with the d-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer’s Disease Transgenic Mice
- (2010) Susanne Aileen Funke et al. ACS Chemical Neuroscience
- Cocaine-induced neuroadaptations in glutamate transmission
- (2010) Heath D. Schmidt et al. Annals of the New York Academy of Sciences
- Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice
- (2010) Karla Kopec et al. BIOCHEMICAL PHARMACOLOGY
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Glycine transport accounts for the differential role of glycine vs. d-serine at NMDA receptor coagonist sites in the salamander retina
- (2010) Eric R. Stevens et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- d-Aspartic acid is a novel endogenous neurotransmitter
- (2010) Salvatore D'Aniello et al. FASEB JOURNAL
- Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase
- (2010) S. P. Chung et al. JOURNAL OF BIOCHEMISTRY
- Brain-specificPhgdhDeletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, anN-methyl-d-aspartate Receptor Co-agonist, in Adult Brain
- (2010) Jung Hoon Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Determinants of D-Cycloserine Efficacy at the NR1/NR2C NMDA Receptors
- (2010) S. M. Dravid et al. JOURNAL OF NEUROSCIENCE
- GSK-3β activity and hyperdopamine-dependent behaviors
- (2010) Yan-Chun Li et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia
- (2010) Darrick T. Balu et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- d-Aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices
- (2010) Gemma Molinaro et al. NEUROSCIENCE LETTERS
- MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
- (2010) Joshua D. Vardigan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Glycine serum level in schizophrenia: Relation to negative symptoms
- (2010) Jaromir Hons et al. PSYCHIATRY RESEARCH
- Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve—Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2010) Tokiko Hatano et al. PSYCHIATRY RESEARCH
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia
- (2010) Norell M. Hadzimichalis et al. SCHIZOPHRENIA RESEARCH
- Evidence for the involvement of d-aspartic acid in learning and memory of rat
- (2009) Enza Topo et al. AMINO ACIDS
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
- (2009) V. Labrie et al. GENES BRAIN AND BEHAVIOR
- Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
- (2009) Viviane Labrie et al. HUMAN MOLECULAR GENETICS
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potentd-Amino Acid Oxidase (DAAO) Inhibitors†
- (2009) Allen J. Duplantier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
- (2009) Gregor Habl et al. JOURNAL OF NEURAL TRANSMISSION
- Potential pathophysiological role of d-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain
- (2009) Koji Ono et al. JOURNAL OF NEURAL TRANSMISSION
- PSD-95 Uncouples Dopamine-Glutamate Interaction in the D1/PSD-95/NMDA Receptor Complex
- (2009) J. Zhang et al. JOURNAL OF NEUROSCIENCE
- NOS1AP Regulates Dendrite Patterning of Hippocampal Neurons through a Carboxypeptidase E-Mediated Pathway
- (2009) D. Carrel et al. JOURNAL OF NEUROSCIENCE
- The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine
- (2009) Hai Xia Zhang et al. JOURNAL OF PHYSIOLOGY-LONDON
- The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
- (2009) RM Abou El-Magd et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- The glutamate homeostasis hypothesis of addiction
- (2009) Peter W. Kalivas NATURE REVIEWS NEUROSCIENCE
- Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay
- (2009) Francesco Errico et al. NEUROBIOLOGY OF AGING
- The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist
- (2009) Hai Xia Zhang et al. NEUROPHARMACOLOGY
- Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
- (2009) Felice Iasevoli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride
- (2009) Mark Slifstein et al. SYNAPSE
- Modulation of d-Serine Levels in Brains of Mice Lacking PICK1
- (2008) Takatoshi Hikida et al. BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid d-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients
- (2008) Sabine A. Fuchs et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors
- (2008) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801
- (2008) F. Errico et al. JOURNAL OF NEUROSCIENCE
- The Behavioral and Neurochemical Effects of a Novel D-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and D-Serine
- (2008) S. M. Smith et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- D-Amino acid oxidase activity and expression are increased in schizophrenia
- (2008) P W J Burnet et al. MOLECULAR PSYCHIATRY
- Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
- (2008) A C Basu et al. MOLECULAR PSYCHIATRY
- Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2008) Tohru Ohnuma et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
- (2008) Viviane Labrie et al. PSYCHOPHARMACOLOGY
- Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia
- (2008) P BURNET et al. SCHIZOPHRENIA RESEARCH
- Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia
- (2008) Caroline Madeira et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: Differential regulation by dopamine and glutamate signaling
- (2008) M. Behnam Ghasemzadeh et al. SYNAPSE
- d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
- (2007) Jun-ichi Karasawa et al. BEHAVIOURAL BRAIN RESEARCH
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
- In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties
- (2007) Tiziana Adage et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility
- (2007) Francesco Errico et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- D-Aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons
- (2005) Xiang-Qun Gong et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation